The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy

Autor: Baron R, Freynhagen R, Tölle TR, Cloutier C, Leon T, Murphy TK, Phillips K, A0081007 I.n.v.e.s.t.i.g.a.t.o.r.s. Hans GH, Morlion BJ, Vissers KC, Maeyaert J, Genge AL, Morley Forster P, Lasko B, D'Ignazio G, Borshch Y, Ong Lam M, Tölle T, Mueller Schwefe G, Mueller G, Ueberall M, Schulz Meentzen M, Grunert S, Bonezzi C, Marchettini P, Serrati C, Dalla Toffola E, Bertolini C, Calderon FM, Millan JM, Mateos RG, Hernandez CP, Samper D, De Andres J, Sigholm G, Tuveson B, Vasara S, Ruthstrom L, Runhall B, Sorensen J, Ergin ES, Cakmak A, Oncel S, Lesser HD, Bajwa ZH, Daiz Ramirez M, Nicholson BD, Forde GI, Torres ML, Singer RP, Duerden ME, Gimbel JS, Kaplan JA, Charapata S.G., IOLASCON, Giovanni

Publikováno v: Pain
Pain, 150, 3, pp. 420-7
Pain, 150, 420-7

We evaluated the efficacy of pregabalin in patients with chronic lumbosacral radiculopathy. This randomized, controlled, withdrawal trial included five phases: screening (4-18 days); run-in (4-10 days) to screen out placebo responders; single-blind (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a22f04e5605d9de300ddb477a9ffaace
https://pubmed.ncbi.nlm.nih.gov/20605329

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Bone fractures in patients using tapentadol or oxycodone: an exploratory US claims database study.

Autor: Morlion BJ; Leuven Centre for Algology & Pain Management, Anaesthesiology & Algology, Department of Cardiovascular Sciences, University Hospitals Leuven, University of Leuven, Leuven, Belgium., Margarit C; Pain Unit, Health Department of Alicante-General Hospital, Alicante, Spain.; Neuropharmacology on Pain (NED), Alicante Institute for Health & Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain., Wild I; Global Medical Affairs, Grünenthal GmbH, Aachen, Germany., Karra R; Global Medical Affairs, Grünenthal GmbH, Aachen, Germany., Liedgens H; Health Economics & Outcomes Research, Grünenthal GmbH, Aachen, Germany., Sohns M; Grünenthal Innovation, Drug Development, Data Sciences, Grünenthal GmbH, Aachen, Germany., Finco G; Department of Medical Sciences & Public Health, University of Cagliari, Azienda Ospedaliera Universitaria of Cagliari, Cagliari, Italy.

Publikováno v: Pain management [Pain Manag] 2021 Jan; Vol. 11 (1), pp. 39-47. Date of Electronic Publication: 2020 Sep 30.

European Pain Federation position paper on appropriate opioid use in chronic pain management.

Autor: O'Brien T; Marymount University Hospital & Hospice, Curraheen, Cork, Ireland.; Cork University Hospital, Wilton, Cork and College of Medicine and Health, University College, Cork, Ireland., Christrup LL; Department of Drug Design and Pharmacology, University of Copenhagen, Denmark., Drewes AM; Mech-Sense, Department of Gastroenterology & Hepatology, Aalborg University Hospital, Denmark., Fallon MT; Edinburgh Cancer Research Centre, University of Edinburgh, UK., Kress HG; Department of Special Anaesthesia and Pain Therapy, Medical University of Vienna/AKH, Austria., McQuay HJ; Balliol College, Oxford, UK., Mikus G; Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital, Heidelberg, Germany., Morlion BJ; Leuven Centre for Algology & Pain Management, University Hospital Leuven, Belgium., Perez-Cajaraville J; Pain Functional Unit, University Hospital HM Madrid, Spain., Pogatzki-Zahn E; Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Müenster, Germany., Varrassi G; Paolo Procacci Foundation, Rome, Italy., Wells JC; Pain Matters Ltd, Liverpool, UK.

Publikováno v: European journal of pain (London, England) [Eur J Pain] 2017 Jan; Vol. 21 (1), pp. 3-19.